Knut Breistøl

Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.

Gjermund Henriksen, Knut Breistøl, Øyvind S. Bruland et al. · PubMed · 2002 · 281 citations

Engineering, Pathology, Significant Antitumor Effect +18

Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.

Knut Breistøl, Jan Balzarini, Marit Liland Sandvold et al. · PubMed · 1999 · 70 citations

Nude Rats, Tumor Biology, Antitumor Activity +13

Human osteosarcoma xenografts and their sensitivity to chemotherapy

Skjalg Bruheim, Øyvind S. Bruland, Knut Breistøl et al. · Pathology & Oncology Research · 2004 · 42 citations

Medicine, Pathology, Cancer Treatment +3

Antiproliferative Activity and Mechanism of Action of Fatty Acid Derivatives of Gemcitabine in Leukemia and Solid Tumor Cell Lines and in Human Xenografts

Andries M. Bergman, Catharina M. Kuiper, Paul Noordhuis et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 34 citations · Full text

The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts

Knut Breistøl, Hans R. Hendriks, Dan Berger et al. · European Journal of Cancer · 1998 · 33 citations

Medicinal Chemistry, Human Tumour Xenografts, Prodrug N-l-leucyl-doxorubicin +10